Black Women Are More Likely Than White Women to Schedule a Uterine-Sparing Treatment for Leiomyomas

Background: To evaluate differences in the proportion of uterine fibroid (UF) treatments that are uterine-sparing between Black women and White identify factors could explain disparities. Methods: Women at age 18–54 years who were enrolled from 10 clinical sites United States into Comparing Options for Management: Patient-Centered Results UFs (COMPARE-UF) treatment registry completed questionnaires before their UF procedure. symptoms quality life assessed by questionnaires. Details on imaging (hysterectomy, myomectomy, or artery embolization [UAE]) collected each patient's medical record. Random-effects logistic regression was used to assess association race odds having a procedure versus hysterectomy. Subgroup analyses compared with Results: In this cohort 1141 1196 women, tended be younger (median 41.0 vs. 42.0 years) report worse symptoms, pain, function every scale women. more likely have had prior (22.8% 14.6%). hysterectomies (43.6% 32.2%) myomectomies (50.9% 50.2%) UAEs (15.1% 4.7%) than After adjusting site other variables, greater myomectomy (odds ratio [OR] = 2.41, 95% confidence interval [CI] 1.63–3.56) UAE hysterectomy (OR 4.24, CI 2.41–7.46). Conclusion: these participants, schedule nonsurgical counterparts; may not true all Longer comparative effectiveness studies needed inform about durability treatments. Greater understanding influencing selection is as include without access tertiary care centers. Clinical Trial Registration: Clinicaltrials.gov, NCT02260752 (enrollment start: November 2015).